Federal Register / Vol. 87, No. 130 / Friday, July 8, 2022 / Notices 40845 

seis@cdc.gov. Telephone: 770–488– 

8170. 

SUPPLEMENTARY INFORMATION: On 

January 28, 2022, CDC published a 

Notice of Intent to prepare an SEIS in 

the Federal Register (87 FR 4603). CDC 

has prepared a Draft SEIS to analyze the 

potential impacts of additional 

proposed components that were not 

analyzed in the 2014 Final EIS. The 

proposed components include the 

addition of a Hospital, Medical, and 

Infectious Waste Incinerator (HMIWI) in 

a new laboratory and two emergency 

standby power diesel generators. The 

construction of a new laboratory was 

included in the 2014 Final EIS and will 

not be re-evaluated in the SEIS. 

In accordance with the National 

Environmental Policy Act (NEPA) as 

implemented by Council on 

Environmental Quality (CEQ) 

regulations (Code of Federal Regulations 

Title 40, Section 1507.3) and HHS 

environmental procedures, CDC 

prepared a Draft SEIS to analyze the 

effects of additional proposed 

components that were not analyzed in 

the 2014 Final EIS. The potential 

impacts of construction and operation of 

these components on the natural and 

built environment are being evaluated. 

Under NEPA, federal agencies are 

required to evaluate the environmental 

effects of their proposed actions and a 

range of feasible alternatives to the 

proposed actions prior to making a final 

decision about what actions to take. The 

Draft SEIS incorporates the 2014 Final 

EIS by reference and builds upon that 

document to focus on specific resource 

areas that would have potential effects 

that will differ from those analyzed in 

the 2014 Final EIS. 

Alternatives Considered 

CDC analyzed two alternatives in the 

Draft SEIS: The Proposed Action 

(Alternative 1) and the No Action 

Alternative. Alternative 1 consists of the 

construction and operation of a HMIWI 

in a new laboratory building and the 

operation of two emergency standby 

power diesel generators. The No Action 

Alternative consists of the construction 

of the new laboratory without the 

HMIWI and two emergency standby 

power generators. 

The Draft SEIS evaluates the 

environmental impacts that may result 

from Alternative 1 and the No Action 

Alternative on the following resource 

categories: air quality, climate change 

and sustainability, environmental 

justice, and hazardous/medical/ 

infectious waste. The Draft SEIS 

identifies measures to mitigate potential 

adverse impacts. 

Availability of the Draft SEIS: Notice 

of the Availability of the Draft SEIS has 

been provided to Federal, State, and 

local agencies and organizations via 

hard copy letter or electronic mail to the 

interested parties list. The public is 

being notified of the availability of the 

Draft SEIS through this Federal Register 

publication and a notice published in 

The Atlanta Journal—Constitution. The 

Draft SEIS is available online on the 

Federal eRulemaking Portal identified 

by Docket No. CDC–2022–0014. Hard 

copies of the Draft SEIS are available at 

the following six locations: Decatur 

Library, 215 Sycamore Street, Decatur, 

GA 30030; Toco Hill-Avis G. Williams 

Library, 1282 McConnell Drive, Decatur, 

GA 30030; Atlanta-Fulton Public 

Library, Ponce de Leon Branch, 980 

Ponce de Leon Ave. NE, Atlanta, GA 

30306; Atlanta-Fulton Public Library, 

Central Library, One Margaret Mitchell 

Square, Atlanta, GA 30303; AtlantaFulton Public Library, Kirkwood 

Branch, 11 Kirkwood Rd. NE, Atlanta, 

GA 30317; and Emory University Robert 

W. Woodruff Library, 540 Asbury Cir., 

Atlanta, GA 30322. 

Public Meeting: A virtual public 

meeting will be held on July 27, 2022, 

from 6:00 p.m. EST to 8:00 p.m. EST. 

This meeting will occur via the Zoom 

platform. Please register at https://

us06web.zoom.us/meeting/register/ 

tZ0vduiqrT8oEtfyyzvqDUn_oUl5nSLvfUE. 

Registration is required prior to the 

meeting. Once registered, you will 

receive an email with the meeting link 

and call-in number. 

The meeting will start with a formal 

presentation and will be followed by a 

period during which the public can 

comment or ask questions. A 

stenographer will transcribe the public 

meeting. A transcript of the meeting will 

be made available to the public and will 

be posted to the public docket at 

www.regulations.gov, identified by 

Docket No. CDC–2012–0014. CDC will 

provide a response to comments in the 

Final SEIS. 

Dated: July 1, 2022. 

Angela K. Oliver, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2022–14518 Filed 7–7–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; National 

and Tribal Evaluation of the 2nd 

Generation of the Health Profession 

Opportunity Grants (OMB #0970–0462) 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Health Profession 

Opportunity Grants (HPOG) Program 

provides healthcare occupational 

training for Temporary Assistance for 

Needy Families recipients and other 

individuals with low incomes. The 

Office of Management and Budget 

(OMB) has approved various data 

collection activities for the National and 

Tribal Evaluation of the 2nd Generation 

of HPOG (HPOG 2.0 National and Tribal 

Evaluation) under OMB #0970–0462. 

The Administration for Children and 

Families’ (ACF) Office of Planning, 

Research, and Evaluation (OPRE) is now 

preparing to conduct the HPOG 2.0 

Long-Term Follow-Up Study of HPOG 

2.0 participants 51⁄2 years after study 

enrollment, using a long-term survey 

(LTS) and administrative data. This 

notice provides a summary for public 

review and comment of the use and 

burden associated with the LTS 

instrument. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also obtain 

copies of the proposed collection of 

information by emailing 

OPREinfocollection@acf.hhs.gov. 

Identify all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The HPOG 2.0 evaluation 

of non-tribal programs is assessing the 

implementation and impacts of HPOG 


jspears on DSK121TN23PROD with NOTICES1
40846 Federal Register / Vol. 87, No. 130 / Friday, July 8, 2022 / Notices 

in non-tribal HPOG programs and will 

include a cost-benefit analysis. Key 

participant outcomes of interest include 

(but are not limited to) educational 

progress, employment, and earnings. 

The HPOG 2.0 Long-Term Follow-Up 

Study will use survey and 

administrative data to estimate longerterm (approximately 51⁄2 years after 

random assignment) program impacts at 

the local and national level and to 

explore characteristics of local programs 

that are associated with more favorable 

outcomes. By extending data collection 

to include an LTS, OPRE can address 

important unanswered questions for 

policymakers and practitioners. The 

HPOG 2.0 LTS specifically will provide 

insights into the long-term impacts of 

HPOG 2.0 for outcomes that are not 

captured in administrative records, such 

as details about educational 

experiences, characteristics of 

employment, self-employment, and 

earnings from jobs not covered in 

administrative data, receipt of public 

assistance, physical and mental wellbeing, and child outcomes. There are 

two versions of the HPOG 2.0 LTS, the 

full version (Instrument 21) and a 

shorter version with critical items of 

interest only (Instrument 21a). 

Instrument 21a will be offered to 

reluctant participants who would 

otherwise not complete the survey to 

help maximize response rates and 

reduce item non-response for the most 

critical outcomes in the study. 

Respondents: HPOG 2.0 impact study 

participants from the 27 non-tribal 

HPOG 2.0 grantees (treatment and 

control group members) who enrolled 

between September 2017 and January 

2018. 

Annual Burden Estimates: This 

request is specific to the HPOG 2.0 

Long-Term Follow-Up Survey (LTS) 

(both the full and critical items only 

versions). Currently approved materials 

and associated burden, which we plan 

to continue to use can be found at: 

https://www.reginfo.gov/public/do/ 

PRAICList?ref_nbr=201904-0970-006. 

Instrument 

Number of 

respondents 

(total over 

request 

period) 

Number of 

responses per 

respondent 

(total over 

request 

period) 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Annual burden 

(in hours) 

Instrument 21a: HPOG 2.0 Long-Term Survey ................... 3,064 1 1 3,064 1,021 

Instrument 21a: HPOG 2.0 Long-Term Survey Critical 

Items Instrument ............................................................... 541 1 0.33 179 60 

Total .............................................................................. 3,605 ........................ ........................ 3,243 1,081 

Estimated Total Annual Burden 

Hours: 1,081. 

Authority: Section 2008 of the Social 

Security Act as enacted by section 5507 

of the Affordable Care Act and section 

413 of the Social Security Act, 42 U.S.C. 

613. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–14580 Filed 7–7–22; 8:45 am] 

BILLING CODE 4184–72–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2018–D–0388] 

Hazard Analysis and Risk-Based 

Preventive Controls for Food for 

Animals; Guidance for Industry; 

Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of availability. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing the availability of a final 

guidance for industry #245 entitled 

‘‘Hazard Analysis and Risk-Based 

Preventive Controls for Food for 

Animals.’’ This final guidance 

document is intended to help animal 

food facilities comply with the 

requirements for hazard analysis and 

risk-based preventive controls under our 

regulation ‘‘Current Good 

Manufacturing Practice, Hazard 

Analysis, and Risk-Based Preventive 

Controls for Food for Animals.’’ The 

guidance announced in this notice 

finalizes the draft guidance of the same 

title dated January 23, 2018. 

DATES: The announcement of the 

guidance is published in the Federal 

Register on July 8, 2022. 

ADDRESSES: You may submit either 

electronic or written comments on 

Agency guidances at any time as 

follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2018–D–0388 for ‘‘Hazard Analysis and 

Risk-Based Preventive Controls for Food 

for Animals.’’ Received comments will 

be placed in the docket and, except for 

those submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 


jspears on DSK121TN23PROD with NOTICES1